AstraZeneca’s non-small lung cancer therapy gets FDA clearance
HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..
HQ Team February 16, 2024: The U.S. Food and Drug Administration (FDA) has approved the first-ever drug, iloprost, to treat severe frostbite in.
By K. Leelamoni February 15, 2024: Autism Spectrum Disorders are a diverse group of conditions related to brain development and characterised by some.
HQ Team February 15, 2024: The US state of Oregon has confirmed its first case of bubonic plague in eight years and authorities.
HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.
 HQ Team February 12, 2024: People with depression may have higher body temperatures and lowering the heat is likely to be beneficial to.
HQ Team February 12, 2024: Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous.
HQ Team February 10, 2024: A study on smoking carried out by the University of Toronto says that people who quit smoking at.
HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.
HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com